|
1
|
American Cancer Society: Cancer Facts
& Figures 2015. American Cancer Society, Inc. Atlanta, GA:
2015.
|
|
2
|
Ademuyiwa FO and Olopade OI: Racial
differences in genetic factors associated with breast cancer.
Cancer Metastasis Rev. 22:47–53. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chlebowski RT, Chen Z, Anderson GL, Rohan
T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell
FA, et al: Ethnicity and breast cancer: Factors influencing
differences in incidence and outcome. J Natl Cancer Inst.
97:439–448. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Polite BN and Olopade OI: Breast cancer
and race: A rising tide does not lift all boats equally. Perspect
Biol Med. 48(Suppl 1): S166–S175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
American Cancer Society: Breast Cancer
Facts & Figures 2013–2014. American Cancer Society, Inc.
Atlanta, GA: 2013.
|
|
6
|
Keeton KM, Jones ES and Sebastian S:
Breast cancer in Mississippi: Impact of race and residential
geographical setting on cancer at initial diagnosis. South Med J.
107:510–512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
DeLancey JO, Thun MJ, Jemal A and Ward EM:
Recent trends in Black-White disparities in cancer mortality.
Cancer Epidemiol Biomarkers Prev. 17:2908–2912. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hunt BR, Whitman S and Hurlbert MS:
Increasing black: White disparities in breast cancer mortality in
the 50 largest cities in the United States. Cancer Epidemiol.
38:118–123. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McCarthy AM, Yamartino P, Yang J, Bristol
M, Conant EF and Armstrong K: Racial differences in false-positive
mammogram rates: Results from the ACRIN digital mammographic
imaging screening trial (DMIST). Med Care. 53:673–678. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li CI, Malone KE and Daling JR:
Differences in breast cancer stage, treatment, and survival by race
and ethnicity. Arch Intern Med. 163:49–56. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Porter PL, Lund MJ, Lin MG, Yuan X, Liff
JM, Flagg EW, Coates RJ and Eley JW: Racial differences in the
expression of cell cycle-regulatory proteins in breast carcinoma.
Cancer. 100:2533–2542. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Amend K, Hicks D and Ambrosone CB: Breast
cancer in African-American women: Differences in tumor biology from
European-American women. Cancer Res. 66:8327–8330. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sarker M, Jatoi I and Becher H: Racial
differences in breast cancer survival in women under age 60. Breast
Cancer Res Treat. 106:135–141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baquet CR, Mishra SI, Commiskey P, Ellison
GL and DeShields M: Breast cancer epidemiology in blacks and
whites: Disparities in incidence, mortality, survival rates and
histology. J Natl Med Assoc. 100:480–488. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rakha EA, Reis-Filho JS, Baehner F, Dabbs
DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani
SR, et al: Breast cancer prognostic classification in the molecular
era: The role of histological grade. Breast Cancer Res.
12:2072010.PubMed/NCBI
|
|
16
|
Soerjomataram I, Louwman MW, Ribot JG,
Roukema JA and Coebergh JW: An overview of prognostic factors for
long-term survivors of breast cancer. Breast Cancer Res Treat.
107:309–330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Henson DE, Chu KC and Levine PH:
Histologic grade, stage and survival in breast carcinoma:
Comparison of African American and Caucasian women. Cancer.
98:908–917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cunningham JE and Butler WM: Racial
disparities in female breast cancer in South Carolina: Clinical
evidence for a biological basis. Breast Cancer Res Treat.
88:161–176. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual (7th).
Springer-Verlag. New York, NY: 2010.
|
|
20
|
Albain KS, Unger JM, Crowley JJ, Coltman
CA Jr and Hershman DL: Racial disparities in cancer survival among
randomized clinical trials patients of the southwest oncology
group. J Natl Cancer Inst. 101:984–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mancino AT, Rubio IT, Henry-Tillman R,
Smith LF, Landes R, Spencer HJ, Erkman L and Klimberg VS: Racial
differences in breast cancer survival: The effect of residual
disease. J Surg Res. 100:161–165. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Danforth DN Jr: Disparities in breast
cancer outcomes between Caucasian and African American women: A
model for describing the relationship of biological and
nonbiological factors. Breast Cancer Res. 15:2082013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iqbal J, Ginsburg O, Rochon PA, Sun P and
Narod SA: Differences in breast cancer stage at diagnosis and
cancer-specific survival by race and ethnicity in the United
States. JAMA. 313:165–173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Balan V, Nangia-Makker P, Schwartz AG,
Jung YS, Tait L, Hogan V, Raz T, Wang Y, Yang ZQ, Wu GS, et al:
Racial disparity in breast cancer and functional germ line mutation
in galectin-3 (rs4644): A pilot study. Cancer Res. 68:10045–10050.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Field LA, Love B, Deyarmin B, Hooke JA,
Shriver CD and Ellsworth RE: Identification of differentially
expressed genes in breast tumors from African American compared
with Caucasian women. Cancer. 118:1334–1344. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh Kalla S, Tan QW, Brito C, De León M
and De León D: Insulin-like growth factors I and II receptors in
the breast cancer survival disparity among African-American women.
Growth Horm IGF Res. 20:245–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stewart PA, Luks J, Roycik MD, Sang QX and
Zhang J: Differentially expressed transcripts and dysregulated
signaling pathways and networks in African American breast cancer.
PLoS One. 8:e824602013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Quan L, Gong Z, Yao S, Bandera EV, Zirpoli
G, Hwang H, Roberts M, Ciupak G, Davis W, Sucheston L, et al:
Cytokine and cytokine receptor genes of the adaptive immune
response are differentially associated with breast cancer risk in
American women of African and European ancestry. Int J Cancer.
134:1408–1421. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Walko CM, Combest AJ, Spasojevic I, Yu AY,
Bhushan S, Hull JH, Hoskins J, Armstrong D, Carey L, Collicio F and
Dees EC: The effect of aprepitant and race on the pharmacokinetics
of cyclophosphamide in breast cancer patients. Cancer Chemother
Pharmacol. 69:1189–1196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Makhoul I, Klimberg VS, Korourian S,
Henry-Tillman RS, Siegel ER, Westbrook KC and Hutchins LF: Combined
neoadjuvant chemotherapy with bevacizumab improves pathologic
complete response in patients with hormone receptor negative
operable or locally advanced breast cancer. Am J Clin Oncol.
38:74–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff
JM, Flagg EW, Brinton LA, Eley JW and Coates RJ: Racial differences
in diagnosis, treatment and clinical delays in a population-based
study of patients with newly diagnosed breast carcinoma. Cancer.
100:1595–1604. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
George P, Chandwani S, Gabel M, Ambrosone
CB, Rhoads G, Bandera EV and Demissie K: Diagnosis and surgical
delays in African American and white women with early-stage breast
cancer. J Womens Health (Larchmt). 24:209–2017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Griggs JJ, Culakova E, Sorbero ME,
Poniewierski MS, Wolff DA, Crawford J, Dale DC and Lyman GH: Social
and racial differences in selection of breast cancer adjuvant
chemotherapy regimens. J Clin Oncol. 25:2522–2527. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Partridge AH, Wang PS, Winer EP and Avorn
J: Nonadherence to adjuvant tamoxifen therapy in women with primary
breast cancer. J Clin Oncol. 21:602–606. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Morris GJ, Naidu S, Topham AK, Guiles F,
Xu Y, McCue P, Schwartz GF, Park PK, Rosenberg AL, Brill K and
Mitchell EP: Differences in breast carcinoma characteristics in
newly diagnosed African-American and Caucasian patients: A
single-institution compilation compared with the national cancer
institute's surveillance, epidemiology and end results database.
Cancer. 110:876–884. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Barcenas CH, Wells J, Chong D, French J,
Looney SW and Samuel TA: Race as an independent risk factor for
breast cancer survival: Breast cancer outcomes from the medical
college of georgia tumor registry. Clin Breast Cancer. 10:59–63.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ihemelandu CU, Naab TJ, Mezghebe HM,
Makambi KH, Siram SM, Leffall LD Jr, Dewitty RL Jr and Frederick
WA: Basal cell-like (triple-negative) breast cancer, a predictor of
distant metastasis in African American women. Am J Surg.
195:153–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ihemelandu CU, Leffall LD Jr, Dewitty RL,
Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L and Frederick
WA: Molecular breast cancer subtypes in premenopausal and
postmenopausal African-American women: Age-specific prevalence and
survival. J Surg Res. 143:109–118. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lund MJ, Trivers KF, Porter PL, Coates RJ,
Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG and
Eley JW: Race and triple negative threats to breast cancer
survival: A population-based study in Atlanta, GA. Breast Cancer
Res Treat. 113:357–370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Menashe I, Anderson WF, Jatoi I and
Rosenberg PS: Underlying causes of the black-white racial disparity
in breast cancer mortality: A population-based analysis. J Natl
Cancer Inst. 101:993–1000. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schinkel JK, Zahm SH, Jatoi I, McGlynn KA,
Gallagher C, Schairer C, Shriver CD and Zhu K: Racial/ethnic
differences in breast cancer survival by inflammatory status and
hormonal receptor status: An analysis of the surveillance,
epidemiology and end results data. Cancer Causes Control.
25:959–968. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Carey LA, Perou CM, Livasy CA, Dressler
LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S,
et al: Race, breast cancer subtypes, and survival in the Carolina
breast cancer study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bentzon N, Düring M, Rasmussen BB,
Mouridsen H and Kroman N: Prognostic effect of estrogen receptor
status across age in primary breast cancer. Int J Cancer.
122:1089–1094. 2008. View Article : Google Scholar : PubMed/NCBI
|
